SEC Form 4 · accession 0001078782-16-002748
VOLITIONRX LTD · VNRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin Charles Faulkes
Director
Period of report
May 4, 2016
Accepted (ET)
May 6, 2016 · 12:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000093314
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (Right to Buy) | $2.60 | May 4, 2016 | D | 58,034 | D | May 11, 2012 | May 10, 2016 | Common Stock | 58,034 | 0 | D |
| Warrant (Right to Buy) | $2.60 | May 4, 2016 | A | 58,034 | A | May 11, 2012 | May 10, 2017 | Common Stock | 58,034 | 58,034 | D |
Explanation of responses
- F1The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on May 11, 2012 with an expiration date of May 10, 2016. The warrant expiration date was extended one year to May 10, 2017.